We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test “can potentially eliminate the need for time-consuming and expensive PET scans,” said Jeff Shuren, director of the FDA’s Center for Devices and Radiological Health. Read More
Preliminary research showed that the Mirvie RNA platform can identify 75 percent of women who go on to develop preeclampsia, months before symptoms occur. Read More